A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice

Clinical treatment is challenging for elderly patients with lung cancer who cannot tolerate chemotherapy, do not have cancer driver genes, and have low expression of PD-L1. Since these patients are usually excluded from clinical studies, evidence-based medicine supporting the use of immunotherapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hanfei, Qian, Lei, Chen, Xiao, Zhao, Yuguang, Song, Wei, Guan, Yanjie, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678476/
https://www.ncbi.nlm.nih.gov/pubmed/34993345
http://dx.doi.org/10.1515/med-2021-0404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678476/
https://www.ncbi.nlm.nih.gov/pubmed/34993345
http://dx.doi.org/10.1515/med-2021-0404

Ejemplares similares